T2 Biosystems, Inc. 4/A SEC Filings

Filed On	Filing
28 Nov 2023	Form 4/A: Giffin Brett A., Chief Commercial Officer Received 1,333 shares by exercise or conversion · Sold 537 shares ($349)
14 Jul 2023	Form 4/A: Cr Group L.p., 10% owner and 5 others Granted 93,298 Series B Convertible Preferred Stock
05 Apr 2023	Form 4/A: Gibbs Michael Terrence, General Counsel Received 334 shares by exercise or conversion
29 Mar 2022	Form 4/A: Sprague John M, Chief Financial Officer Received 145,719 shares by exercise or conversion · Gave up 55,008 shares to cover exercise price or tax ($24.7K)
29 Mar 2022	Form 4/A: Sprague John M, Chief Financial Officer Granted 600,000 Restricted Stock Units · Received 10,000 shares by exercise or conversion · Gave up 3,775 shares to cover exercise price or tax ($1.76K)
28 Mar 2022	Form 4/A: Gibbs Michael Terrence, General Counsel Received 145,719 shares by exercise or conversion · Gave up 76,867 shares to cover exercise price or tax ($34.5K)
28 Mar 2022	Form 4/A: Gibbs Michael Terrence, General Counsel Granted 600,000 Restricted Stock Units · Received 10,000 shares by exercise or conversion · Gave up 5,275 shares to cover exercise price or tax ($2.46K)
19 Mar 2021	Form 4/A: Sperzel John J Iii, Director Granted 1,000,000 Restricted Stock Units
03 Sep 2015	Form 4/A: Lowery Thomas J., Chief Scientific Officer Received 2,000 shares by exercise or conversion ($4.9K)

Comments